Learn More
Medchemexpress LLC Gisadenafil besylate | 334827-98-4 | 677.79 | 1 ML

Supplier: Medchemexpress LLC HY10861910MG
Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor with an IC50 of 3.6 nM and prevents degradation of cyclic guanosine monophosphate (cGMP).
- Specific, orally active phosphodiesterase 5 (PDE5) inhibitor.
- IC50 for PDE5A is 3.6 nM.
- Inhibits PDE1A with an IC50 of 9.1 μM, showing an approximately 2500-fold difference in specificity for PDE5A.
- In vivo, Gisadenafil (2 mg/kg; intraperitoneal injection) largely restores the normal increase in cortical flow following hypercapnia in Tat-tg mice (17.5% above baseline).
- Restores the dilation of small (<25 μm) arterioles following hypercapnia.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.